The first Genmab trade was made in Q4 2020.
Since then Ron Baron bought shares four more times and sold shares on thirteen occasions. The investor completely sold their stake between Q3 2024 and Q1 2025.
Avg closing price
Price range
Sold -31.7 Thousand shares
Q1 2025
Avg closing price
$21.00
Price range
$18.69
-
$24.14
Sold 56.2% shares (-40.7 Thousand shares)
Q4 2024
Avg closing price
$21.92
Price range
$20.02
-
$24.15
Sold 17.0% shares (-14.8 Thousand shares)
Q3 2024
Avg closing price
$26.73
Price range
$23.83
-
$28.48
Increased shares by 20.7% (+14.9 Thousand shares)
Q2 2024
Avg closing price
$28.35
Price range
$25.13
-
$30.27
Sold 48.0% shares (-66.7 Thousand shares)
Q1 2024
Avg closing price
$29.38
Price range
$26.43
-
$32.77
Sold 6.7% shares (-10 Thousand shares)
Q4 2023
Avg closing price
$31.40
Price range
$27.94
-
$35.44
Sold 9.1% shares (-15 Thousand shares)
Q3 2023
Avg closing price
$38.11
Price range
$35.27
-
$42.24
Sold 3.0% shares (-5 Thousand shares)
Q2 2023
Avg closing price
$39.87
Price range
$37.40
-
$42.94
Sold 21.3% shares (-45.8 Thousand shares)
Q1 2023
Avg closing price
$38.44
Price range
$34.88
-
$43.22
Increased shares by 11.5% (+22.1 Thousand shares)
Q4 2022
Avg closing price
$41.20
Price range
$33.80
-
$47.06
Sold 7.1% shares (-14.8 Thousand shares)
Q3 2022
Avg closing price
$35.11
Price range
$31.52
-
$37.70
Sold 18.8% shares (-48 Thousand shares)
Q2 2022
Avg closing price
$32.40
Price range
$26.83
-
$38.57
Sold 0.9% shares (-2.27 Thousand shares)
Q1 2022
Avg closing price
$34.32
Price range
$30.96
-
$39.68
Sold 2.0% shares (-5.3 Thousand shares)
Q4 2021
Avg closing price
$41.70
Price range
$35.87
-
$47.12
Sold 0.6% shares (-1.5 Thousand shares)
Q3 2021
Avg closing price
$44.89
Price range
$41.55
-
$48.72
Increased shares by 10.5% (+25.1 Thousand shares)
Q2 2021
Avg closing price
$38.59
Price range
$32.88
-
$44.57
Increased shares by 64.8% (+94.2 Thousand shares)
Q1 2021